These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 8393371
1. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, Koeffler HP. Cancer; 1993 Aug 15; 72(4):1272-80. PubMed ID: 8393371 [Abstract] [Full Text] [Related]
3. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Muñoz N, Hedrick L, Cho KR. Am J Pathol; 1993 Nov 15; 143(5):1398-405. PubMed ID: 8238255 [Abstract] [Full Text] [Related]
5. Low frequency of p53 mutations in cervical carcinomas among Brazilian women. Pinheiro NA, Villa LL. Braz J Med Biol Res; 2001 Jun 15; 34(6):727-33. PubMed ID: 11378660 [Abstract] [Full Text] [Related]
7. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K, Sugimori H. Gynecol Oncol; 1993 Jan 15; 48(1):104-9. PubMed ID: 8380785 [Abstract] [Full Text] [Related]
8. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. Lancet; 1992 May 02; 339(8801):1070-3. PubMed ID: 1349102 [Abstract] [Full Text] [Related]
9. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, Shanmugam G. Gynecol Oncol; 1998 Jun 02; 69(3):205-9. PubMed ID: 9648588 [Abstract] [Full Text] [Related]
13. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA. Penhallow J, Steingrimsdottir H, Elamin F, Warnakulasuriya S, Farzaneh F, Johnson N, Tavassoli M. Int J Oncol; 1998 Jan 02; 12(1):59-68. PubMed ID: 9454887 [Abstract] [Full Text] [Related]
14. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma]. Zhao W, Si J, Li K. Zhonghua Fu Chan Ke Za Zhi; 1995 Nov 02; 30(11):654-7. PubMed ID: 8745488 [Abstract] [Full Text] [Related]
17. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Jiko K, Tsuda H, Sato S, Hirohashi S. Int J Cancer; 1994 Dec 01; 59(5):601-6. PubMed ID: 7960232 [Abstract] [Full Text] [Related]
18. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G, Liu W, Hanania EG, Fu S, Wang T, Deisseroth AB. Cancer Gene Ther; 1995 Mar 01; 2(1):19-32. PubMed ID: 7621252 [Abstract] [Full Text] [Related]
19. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Stenzel A, Semczuk A, Rózyńskal K, Jakowicki J, Wojcierowski J. Pathol Res Pract; 2001 Mar 01; 197(9):597-603. PubMed ID: 11569923 [Abstract] [Full Text] [Related]